LOS ANGELES, Aug. 7, 2019 /PRNewswire/ -- Based in Southern California, the surrogacy company Joy of Life was established two years ago. With hard work and meticulous care, a group of enthusiastic and passionate women focused on growing a company that would fulfill the dreams of intended parents with the help of strong surroga

SAN DIEGO, Aug. 7, 2019 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Cambrex Corporation (NYSE: CBM) ("Cambrex") breached their fiduciary duties in connection with the proposed sale of the Company to private equity firm Permira.On August 7, 2019, C

MINNEAPOLIS, Aug. 7, 2019 /PRNewswire/ -- Today, the leaders from the Manova Global Summit on the Future of Health announced that Jane Fonda, Academy Award-winning actress, Co-Founder of the Women's Media Center, Founder of the Georgia Campaign for Adolescent Power & Potential, is participating in the Manova Summit, on

The Co-operators and BDC Capital co-lead investment that will expand AI-driven infectious disease global early warning system TORONTO, August 7, 2019 /PRNewswire/ - BlueDot, a digital health company that uses big data analytics to track and anticipate the spread of the world's most dangerous infectious diseases, announced today that it

GERMANTOWN, Md., Aug. 7, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR) ("Neuralstem" or the  Company") today announced that on August 6, 2019, it received a letter from the Office of General Counsel of The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that the Nasdaq Hearings Panel (the "Panel") has granted the Company'

NEW HAVEN, Conn., Aug. 7, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases today reported completion of enrollment in its pivotal Phase 3 preventive treatment of migraine trial with rimegepant, its lead or

MENLO PARK, Calif., Aug. 7, 2019 /PRNewswire/ -- Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced that Jessica Holmes, Brian Regan and Jim Sluck have joined the company as

ROCKVILLE, Md., Aug. 7, 2019 /PRNewswire/ -- DrFirst announced today their collaboration to deliver single sign-on (SSO) access to HIPAA compliant messaging is now available. Using DrFirst Backline and Imprivata Mobile Device Access to enable fast, secure access to shared mobile devices and applications, users can now securely communicate in real-time across care te

- Presentation scheduled for 2:30 pm ET on August 14, 2019 - VANCOUVER, Aug. 7, 2019 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on advancing targeted therapeutics for the treatment of patients with significant unmet needs in hematology and on

Second quarter 2019 revenue of $131 million Second quarter 2019 net loss of $44 million Second quarter 2019 Adjusted EBITDA1 of $60 million Generated cash flow from operating activities of $97 million in the first six months of 2019 and concluded the quarter wi